SENORESBSESenores Pharmaceuticals LtdMinimalNeutral
Announced Fri, 15 May · 11:14 IST

Senores Pharmaceuticals Limited has informed the Exchange regarding copy of Newspaper Publication for Audited Consolidated and Standalone financial results for quarter and financial year ....

SENORES · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+18.0%1-day move
₹960.00
prior close
₹991.85
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.1+0.1+0.1+0.1+18.0+9.6+13.1+15.4+15.9+20.2+4.7+33.3+54.1
Up moveDown movePending
AI summary

Senores Pharmaceuticals Limited has informed BSE and NSE about the publication of extracts of its audited consolidated and standalone financial results for Q4 and the financial year ended March 31, 2026. The results were published in Financial Express (English and Gujarati editions) on May 15, 2026. This filing is pursuant to Regulation 30 and 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which requires newspaper publication of quarterly and annual financial results. The company has also uploaded this information on its website www.senorespharma.com.

Likely market impact

This is a routine regulatory compliance filing announcing the publication of annual financial results. No immediate impact on shareholders expected as this is a disclosure requirement rather than a financial event.